Dr Wayne Dyer

Research Fellow
Australian Red Cross Blood Service, Central Clinical School

Telephone +61 2 9229 4557
Fax +61 2 9229 4521

Map

Selected grants

2011

  • TLR2 agonist - HIV peptide induction of TH17 reponses: a new immunotherapeutic and vaccine strategy; Cunningham A, Dyer W, Jones C, Fernandez M; Department of Health and Ageing (Federal)/Targeted Prevention Programs.

Selected publications

Download citations: PDF RTF Endnote

Book Chapters

  • Mohamed, A., Lal, S., Ho, J., Brown, A., Lui, R., Nguyen, L., Yong, A., Su, Y., Braet, F., Dyer, W., Junius, F., Cumming, R., Freedman, B., Kritharides, L., Dos Remedios, C. (2010). How to interrogate the cellular immune system in patients with ischemic heart disease. In Dmitry Vukovic & Vladimir Kiyan (Eds.), Myocardial ischemia: Causes, symptoms and treatment, (pp. 195-216). United States: Nova Science Publishers.
  • Lui, R., Brown, A., Wu, B., Lin, M., Thompson, J., Braet, F., Dyer, W., Lattimore, J., Macdonald, P., Adelstein, S., Dos Remedios, C. (2008). Use of Antibody Microarrays in the Analysis of Inflammation, Autoimmunity, Viral Infection, and Cancer Metastases. In J. E. Van Eyk and M. J. Dunn (Eds.), Clinical Proteomics: From Diagnosis to Therapy, (pp. 571-592). Weinheim: Wiley - V C H Verlag GmbH & Co. KGaA.

Journals

  • Czubala, M., Matlho, K., Arriaga, M., Dyer, W., Wang, B., Chew, C., Dwyer, D., Saksena, N. (2012). High frequency of stop codons in the human immunodeficiency virus-1 protease gene frame in human immunodeficiency virus individuals with below detectable levels of plasma viremia during highly active antiretroviral therapy. American Journal of Infectious Diseases, 8(3), 115-122. [More Information]
  • Wu, J., Dwyer, D., Dyer, W., Yang, J., Wang, B., Saksena, N. (2011). Genome-wide analysis of primary CD4+ and CD8+ T cell transcriptomes shows evidence for a network of enriched pathways associated with HIV disease. Retrovirology, 8(18), 1-21. [More Information]
  • Zaunders, J., Dyer, W., Churchill, M. (2011). The Sydney Blood Bank Cohort: implications for viral fitness as a cause of elite control. Current Opinion in HIV and AIDS, 6(3), 151-156. [More Information]
  • Sullivan, J., Selleck, P., Downton, T., Boehm, I., Axell, A., Ayob, Y., Kapitza, N., Dyer, W., Fitzgerald, A., Walsh, B., Lynch, G. (2009). Heterosubtypic anti-avian H5N1 influenza antibodies in intravenous immunoglobulins from globally separate populations protect against H5N1 infection in cell culture. Journal of Molecular and Genetic Medicine, 3(2), 217-224. [More Information]
  • Zaunders, J., Munier, M., Seddiki, N., Pett, S., Ip, S., Bailey, M., Xu, Y., Brown, K., Dyer, W., Kim, M., Cunningham, A., et al (2009). High Levels of Human Antigen-Specific CD4+ T Cells in Peripheral Blood Revealed by Stimulated Coexpression of CD25 and CD134 (OX40). Journal of Immunology, 183(4), 2827-2836. [More Information]
  • Xu, W., Santini, P., Sullivan, J., He, B., Shan, M., Ball, S., Dyer, W., Ketas, T., Chadburn, A., Leona, C., et al (2009). HIV-1 evades virus-specific IgG2 and IgA responses by targeting systemic and intestinal B cells via long-range intercellular conduits. Nature Immunology, 10(9), 1008-1017. [More Information]
  • Lal, S., Brown, A., Nguyen, L., Braet, F., Dyer, W., Dos Remedios, C. (2009). Using antibody arrays to detect microparticles from acute coronary syndrome patients based on Cluster of Differentiation (CD) antigen expression. Molecular and Cellular Proteomics, 8(4), 799-804. [More Information]
  • Lynch, G., Selleck, P., Axell, A., Downton, T., Kaptiza, N., Boehm, I., Dyer, W., Wang, Y., Stelzer-Braid, S., Rawlinson, W., Sullivan, J. (2008). Cross-Reactive Anti-Avian H5N1 Influenza Neutralizing Antibodies in a Normal 'Exposure-Naive' Australian Blood Donor Population. The Open Immunology Journal, 1, 13-19.
  • Wu, J., Dyer, W., Chrisp, J., Belov, L., Wang, B., Saksena, N. (2008). Longitudinal microarray analysis of cell surface antigens on peripheral blood mononuclear cells from HIV+ individuals on highly active antiretroviral therapy. Retrovirology, 5(24), 1-12. [More Information]
  • Dyer, W., Zaunders, J., Yuan, F., Wang, B., Learmont, J., Geczy, A., Saksena, N., McPhee, D., Gorry, P., Sullivan, J. (2008). Mechanisms of HIV non-progression; robust and sustained CD4+ T-cell proliferative responses to p24 antigen correlate with control of viraemia and lack of disease progression after long-term transfusion-acquired HIV-1 infection. Retrovirology, 5, 112-1-112-14. [More Information]
  • Brown, A., Lattimore, J., McGrady, M., Sullivan, D., Dyer, W., Braet, F., Dos Remedios, C. (2008). Stable and unstable angina: Identifying novel markers on circulating leukocytes. Proteomics - Clinical Applications, 2, 90-98. [More Information]
  • Wu, J., Dwyer, D., Dyer, W., Yang, J., Wang, B., Saksena, N. (2008). Transcriptional profiles in CD8+ T cells from HIV+ progressors on HAART are characterized by coordinated up-regulation of oxidative phosphorylation enzymes and interferon responses. Virology, 380(1), 124-135. [More Information]
  • Wu, J., Wang, B., Belov, L., Chrisp, J., Learmont, J., Dyer, W., Zaunders, J., Cunningham, A., Dwyer, D., Saksena, N. (2007). Antibody microarray analysis of cell surface antigens on CD4+ and CD8+ T cells from HIV+ individuals correlates with disease stages. Retrovirology, 4(83), 1-13. [More Information]
  • Yuan, F., Boehm, I., Chan, P., Marks, K., Tang, J., Hui, D., Sung, J., Dyer, W., Geczy, A. (2007). CD14-159CC, another risk genotype for severe SARS-CoV infection. Clinical and Vaccine Immunology, 14(12), 1644-1645. [More Information]
  • Wang, Y., Dyer, W., Workman, C., Wang, B., Peng, N., Lachireddy, K., Chew, C., Sullivan, J., Saksena, N. (2007). Drug resistance and viral evolution in plasma and peripheral blood cells during structured treatment interruption (STI) and non-interrupted HAART. Current HIV Research, 5(2), 235-250. [More Information]
  • Wang, Y., Wang, B., Dyer, W., Lachireddy, K., Peng, N., Saksena, N. (2007). Evidence for predominance of CCR5-using HIV-1 strains during highly active antiretroviral therapy. Current HIV Research, 5(2), 221-234. [More Information]
  • Gorry, P., McPhee, D., Verity, E., Dyer, W., Wesselingh, S., Learmont, J., Sullivan, J., Roche, M., Zaunders, J., Gabuzda, D., Cunningham, A., et al (2007). Pathogenicity and immunogenicity of attenuated, nef-deleted HIV-1 strains in vivo. Retrovirology, 4(66), 1-13. [More Information]
  • Gorry, P., Churchill, M., Learmont, J., Cherry, C., Dyer, W., Wesselingh, S., Sullivan, J. (2007). Replication-Dependent Pathogenicity of Attenuated nef-Deleted HIV-1 In Vivo. JAIDS-Journal of Acquired Immune Deficiency Syndromes, 46(4), 390-394. [More Information]
  • Verity, E., Zotos, D., Wilson, K., Chatfield, C., Lawson, V., Dwyer, D., Cunningham, A., Learmont, J., Dyer, W., Sullivan, J., et al (2007). Viral phenotypes and antibody responses in long-term survivors infected with attenuated human immunodeficiency virus type 1 containing deletions in the nef and long terminal repeat region. Journal of Virology, 81(17), 9268-9278. [More Information]
  • Zaunders, J., Dyer, W., Munier, M., Ip, S., Liu, J., Amyes, E., Rawlinson, W., De Rose, R., Kent, S., Sullivan, J., et al (2006). CD127 CCR5 CD38 CD4 Th1 effector cells are an early component of the primary immune response to vaccinia virus and precede development of interleukin-2() memory CD4() T cells. Journal of Virology, 80(20), 10151-10161. [More Information]
  • Potter, S., Lemey, P., Dyer, W., Sullivan, J., Chew, C., Vandamme, A., Dwyer, D., Saksena, N. (2006). Genetic analyses reveal structured HIV-1 populations in serially sampled T lymphocytes of patients receiving HAART. Virology, 348(1), 35-46. [More Information]
  • Dyer, W., Pett, S., Sullivan, J., Emery, S., Cooper, D., Kelleher, A., Lloyd, A., Lewin, S. (2006). Substantial improvements in performance indicators achieved in a PBMC cryopreservation quality assurance program using single donor samples. Clinical and Vaccine Immunology, 14(1), 52-59. [More Information]
  • Yuan, F., Tanner, J., Chan, P., Biffin, S., Dyer, W., Geczy, A., Tang, J., Hui, D., Sung, J., Sullivan, J. (2005). Influence of FcgammaRIIA and MBL polymorphisms on severe acute respiratory syndrome. Tissue Antigens: immune response genetics, 66(4), 291-296. [More Information]
  • Dyer, W., Learmont, J., Geczy, A., Sullivan, J. (2004). High frequency of nonprogression 20 years after transfusion-transmitted human immunodeficiency virus type-1 infection. Transfusion, 44(9), 1397-1398.
  • Zaunders, J., Dyer, W., Wang, B., Munier, M., Miranda Saksena, M., Newton, R., Moore, J., Mackay, C., Cooper, D., Saksena, N., et al (2004). Identification Of Circulating Antigen-Specific Cd4+ T Lymphocytes With A Ccr5+, Cytotoxic Phenotype In An Hiv-1 Long-Term Nonprogressor And In Cmv Infection. Blood, 103(6), 2238-2247.
  • Dyer, W., Kuipers, H., Coolen, M., Geczy, A., Forrester, J., Workman, C., Sullivan, J. (2002). Correlates of antiviral immune restoration in acute and chronic HIV type 1 infection: sustained viral suppression and normalization of T cell subsets. AIDS Research and Human Retroviruses, 18(14), 999-1010.
  • Geczy, A., Kuipers, H., Coolen, M., Ashton, L., Kennedy, C., Ng, G., Dodd, R., Wallace, R., Le, T., Raynes-Greenow, C., Dyer, W., Learmont, J., Sullivan, J. (2000). HLA and other host factors in transfusion-acquired HIV-1 infection. Human Immunology, 61, 172-176.

2012

  • Czubala, M., Matlho, K., Arriaga, M., Dyer, W., Wang, B., Chew, C., Dwyer, D., Saksena, N. (2012). High frequency of stop codons in the human immunodeficiency virus-1 protease gene frame in human immunodeficiency virus individuals with below detectable levels of plasma viremia during highly active antiretroviral therapy. American Journal of Infectious Diseases, 8(3), 115-122. [More Information]

2011

  • Wu, J., Dwyer, D., Dyer, W., Yang, J., Wang, B., Saksena, N. (2011). Genome-wide analysis of primary CD4+ and CD8+ T cell transcriptomes shows evidence for a network of enriched pathways associated with HIV disease. Retrovirology, 8(18), 1-21. [More Information]
  • Zaunders, J., Dyer, W., Churchill, M. (2011). The Sydney Blood Bank Cohort: implications for viral fitness as a cause of elite control. Current Opinion in HIV and AIDS, 6(3), 151-156. [More Information]

2010

  • Mohamed, A., Lal, S., Ho, J., Brown, A., Lui, R., Nguyen, L., Yong, A., Su, Y., Braet, F., Dyer, W., Junius, F., Cumming, R., Freedman, B., Kritharides, L., Dos Remedios, C. (2010). How to interrogate the cellular immune system in patients with ischemic heart disease. In Dmitry Vukovic & Vladimir Kiyan (Eds.), Myocardial ischemia: Causes, symptoms and treatment, (pp. 195-216). United States: Nova Science Publishers.

2009

  • Sullivan, J., Selleck, P., Downton, T., Boehm, I., Axell, A., Ayob, Y., Kapitza, N., Dyer, W., Fitzgerald, A., Walsh, B., Lynch, G. (2009). Heterosubtypic anti-avian H5N1 influenza antibodies in intravenous immunoglobulins from globally separate populations protect against H5N1 infection in cell culture. Journal of Molecular and Genetic Medicine, 3(2), 217-224. [More Information]
  • Zaunders, J., Munier, M., Seddiki, N., Pett, S., Ip, S., Bailey, M., Xu, Y., Brown, K., Dyer, W., Kim, M., Cunningham, A., et al (2009). High Levels of Human Antigen-Specific CD4+ T Cells in Peripheral Blood Revealed by Stimulated Coexpression of CD25 and CD134 (OX40). Journal of Immunology, 183(4), 2827-2836. [More Information]
  • Xu, W., Santini, P., Sullivan, J., He, B., Shan, M., Ball, S., Dyer, W., Ketas, T., Chadburn, A., Leona, C., et al (2009). HIV-1 evades virus-specific IgG2 and IgA responses by targeting systemic and intestinal B cells via long-range intercellular conduits. Nature Immunology, 10(9), 1008-1017. [More Information]
  • Lal, S., Brown, A., Nguyen, L., Braet, F., Dyer, W., Dos Remedios, C. (2009). Using antibody arrays to detect microparticles from acute coronary syndrome patients based on Cluster of Differentiation (CD) antigen expression. Molecular and Cellular Proteomics, 8(4), 799-804. [More Information]

2008

  • Lynch, G., Selleck, P., Axell, A., Downton, T., Kaptiza, N., Boehm, I., Dyer, W., Wang, Y., Stelzer-Braid, S., Rawlinson, W., Sullivan, J. (2008). Cross-Reactive Anti-Avian H5N1 Influenza Neutralizing Antibodies in a Normal 'Exposure-Naive' Australian Blood Donor Population. The Open Immunology Journal, 1, 13-19.
  • Wu, J., Dyer, W., Chrisp, J., Belov, L., Wang, B., Saksena, N. (2008). Longitudinal microarray analysis of cell surface antigens on peripheral blood mononuclear cells from HIV+ individuals on highly active antiretroviral therapy. Retrovirology, 5(24), 1-12. [More Information]
  • Dyer, W., Zaunders, J., Yuan, F., Wang, B., Learmont, J., Geczy, A., Saksena, N., McPhee, D., Gorry, P., Sullivan, J. (2008). Mechanisms of HIV non-progression; robust and sustained CD4+ T-cell proliferative responses to p24 antigen correlate with control of viraemia and lack of disease progression after long-term transfusion-acquired HIV-1 infection. Retrovirology, 5, 112-1-112-14. [More Information]
  • Brown, A., Lattimore, J., McGrady, M., Sullivan, D., Dyer, W., Braet, F., Dos Remedios, C. (2008). Stable and unstable angina: Identifying novel markers on circulating leukocytes. Proteomics - Clinical Applications, 2, 90-98. [More Information]
  • Wu, J., Dwyer, D., Dyer, W., Yang, J., Wang, B., Saksena, N. (2008). Transcriptional profiles in CD8+ T cells from HIV+ progressors on HAART are characterized by coordinated up-regulation of oxidative phosphorylation enzymes and interferon responses. Virology, 380(1), 124-135. [More Information]
  • Lui, R., Brown, A., Wu, B., Lin, M., Thompson, J., Braet, F., Dyer, W., Lattimore, J., Macdonald, P., Adelstein, S., Dos Remedios, C. (2008). Use of Antibody Microarrays in the Analysis of Inflammation, Autoimmunity, Viral Infection, and Cancer Metastases. In J. E. Van Eyk and M. J. Dunn (Eds.), Clinical Proteomics: From Diagnosis to Therapy, (pp. 571-592). Weinheim: Wiley - V C H Verlag GmbH & Co. KGaA.

2007

  • Wu, J., Wang, B., Belov, L., Chrisp, J., Learmont, J., Dyer, W., Zaunders, J., Cunningham, A., Dwyer, D., Saksena, N. (2007). Antibody microarray analysis of cell surface antigens on CD4+ and CD8+ T cells from HIV+ individuals correlates with disease stages. Retrovirology, 4(83), 1-13. [More Information]
  • Yuan, F., Boehm, I., Chan, P., Marks, K., Tang, J., Hui, D., Sung, J., Dyer, W., Geczy, A. (2007). CD14-159CC, another risk genotype for severe SARS-CoV infection. Clinical and Vaccine Immunology, 14(12), 1644-1645. [More Information]
  • Wang, Y., Dyer, W., Workman, C., Wang, B., Peng, N., Lachireddy, K., Chew, C., Sullivan, J., Saksena, N. (2007). Drug resistance and viral evolution in plasma and peripheral blood cells during structured treatment interruption (STI) and non-interrupted HAART. Current HIV Research, 5(2), 235-250. [More Information]
  • Wang, Y., Wang, B., Dyer, W., Lachireddy, K., Peng, N., Saksena, N. (2007). Evidence for predominance of CCR5-using HIV-1 strains during highly active antiretroviral therapy. Current HIV Research, 5(2), 221-234. [More Information]
  • Gorry, P., McPhee, D., Verity, E., Dyer, W., Wesselingh, S., Learmont, J., Sullivan, J., Roche, M., Zaunders, J., Gabuzda, D., Cunningham, A., et al (2007). Pathogenicity and immunogenicity of attenuated, nef-deleted HIV-1 strains in vivo. Retrovirology, 4(66), 1-13. [More Information]
  • Gorry, P., Churchill, M., Learmont, J., Cherry, C., Dyer, W., Wesselingh, S., Sullivan, J. (2007). Replication-Dependent Pathogenicity of Attenuated nef-Deleted HIV-1 In Vivo. JAIDS-Journal of Acquired Immune Deficiency Syndromes, 46(4), 390-394. [More Information]
  • Verity, E., Zotos, D., Wilson, K., Chatfield, C., Lawson, V., Dwyer, D., Cunningham, A., Learmont, J., Dyer, W., Sullivan, J., et al (2007). Viral phenotypes and antibody responses in long-term survivors infected with attenuated human immunodeficiency virus type 1 containing deletions in the nef and long terminal repeat region. Journal of Virology, 81(17), 9268-9278. [More Information]

2006

  • Zaunders, J., Dyer, W., Munier, M., Ip, S., Liu, J., Amyes, E., Rawlinson, W., De Rose, R., Kent, S., Sullivan, J., et al (2006). CD127 CCR5 CD38 CD4 Th1 effector cells are an early component of the primary immune response to vaccinia virus and precede development of interleukin-2() memory CD4() T cells. Journal of Virology, 80(20), 10151-10161. [More Information]
  • Potter, S., Lemey, P., Dyer, W., Sullivan, J., Chew, C., Vandamme, A., Dwyer, D., Saksena, N. (2006). Genetic analyses reveal structured HIV-1 populations in serially sampled T lymphocytes of patients receiving HAART. Virology, 348(1), 35-46. [More Information]
  • Dyer, W., Pett, S., Sullivan, J., Emery, S., Cooper, D., Kelleher, A., Lloyd, A., Lewin, S. (2006). Substantial improvements in performance indicators achieved in a PBMC cryopreservation quality assurance program using single donor samples. Clinical and Vaccine Immunology, 14(1), 52-59. [More Information]

2005

  • Yuan, F., Tanner, J., Chan, P., Biffin, S., Dyer, W., Geczy, A., Tang, J., Hui, D., Sung, J., Sullivan, J. (2005). Influence of FcgammaRIIA and MBL polymorphisms on severe acute respiratory syndrome. Tissue Antigens: immune response genetics, 66(4), 291-296. [More Information]

2004

  • Dyer, W., Learmont, J., Geczy, A., Sullivan, J. (2004). High frequency of nonprogression 20 years after transfusion-transmitted human immunodeficiency virus type-1 infection. Transfusion, 44(9), 1397-1398.
  • Zaunders, J., Dyer, W., Wang, B., Munier, M., Miranda Saksena, M., Newton, R., Moore, J., Mackay, C., Cooper, D., Saksena, N., et al (2004). Identification Of Circulating Antigen-Specific Cd4+ T Lymphocytes With A Ccr5+, Cytotoxic Phenotype In An Hiv-1 Long-Term Nonprogressor And In Cmv Infection. Blood, 103(6), 2238-2247.

2002

  • Dyer, W., Kuipers, H., Coolen, M., Geczy, A., Forrester, J., Workman, C., Sullivan, J. (2002). Correlates of antiviral immune restoration in acute and chronic HIV type 1 infection: sustained viral suppression and normalization of T cell subsets. AIDS Research and Human Retroviruses, 18(14), 999-1010.

2000

  • Geczy, A., Kuipers, H., Coolen, M., Ashton, L., Kennedy, C., Ng, G., Dodd, R., Wallace, R., Le, T., Raynes-Greenow, C., Dyer, W., Learmont, J., Sullivan, J. (2000). HLA and other host factors in transfusion-acquired HIV-1 infection. Human Immunology, 61, 172-176.

To update your profile click here. For support on your academic profile contact .